160 related articles for article (PubMed ID: 7846031)
1. T cells induce terminal differentiation of transformed B cells to mature plasma cell tumors.
Hilbert DM; Shen MY; Rapp UR; Rudikoff S
Proc Natl Acad Sci U S A; 1995 Jan; 92(3):649-53. PubMed ID: 7846031
[TBL] [Abstract][Full Text] [Related]
2. Murine plasmacytomas, carrier of the t(12;15) chromosomal translocation, develop from immature/mature B cells not from differentiated plasma cells.
Ohno S; Hayakawa J; Hashimoto N; Wiener F
Carcinogenesis; 1999 Apr; 20(4):529-38. PubMed ID: 10223178
[TBL] [Abstract][Full Text] [Related]
3. Anaplastic, plasmablastic, and plasmacytic plasmacytomas of mice: relationships to human plasma cell neoplasms and late-stage differentiation of normal B cells.
Qi CF; Zhou JX; Lee CH; Naghashfar Z; Xiang S; Kovalchuk AL; Fredrickson TN; Hartley JW; Roopenian DC; Davidson WF; Janz S; Morse HC
Cancer Res; 2007 Mar; 67(6):2439-47. PubMed ID: 17363561
[TBL] [Abstract][Full Text] [Related]
4. A retrovirus that expresses v-abl and c-myc oncogenes rapidly induces plasmacytomas.
Largaespada DA; Kaehler DA; Mishak H; Weissinger E; Potter M; Mushinski JF; Risser R
Oncogene; 1992 Apr; 7(4):811-9. PubMed ID: 1565479
[TBL] [Abstract][Full Text] [Related]
5. Defective development of pristane-oil-induced plasmacytomas in interleukin-6-deficient BALB/c mice.
Lattanzio G; Libert C; Aquilina M; Cappelletti M; Ciliberto G; Musiani P; Poli V
Am J Pathol; 1997 Sep; 151(3):689-96. PubMed ID: 9284817
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of v-abl uniquely cooperates with c-myc dysregulation in induction of plasma cell tumors, bypassing the need for T-lymphocytic help and overcoming T-lymphocytic interference.
Weissinger EM; Byrd LG; Henderson DW; Mushinski JF
Int J Cancer; 1996 Jul; 67(1):142-7. PubMed ID: 8690515
[TBL] [Abstract][Full Text] [Related]
7. v-myc and v-raf act synergistically to induce B-cell tumors in pristane-primed adult BALBC mice.
Kurie JM; Morse HC; Principato MA; Wax JS; Troppmair J; Rapp UR; Potter M; Mushinski JF
Oncogene; 1990 Apr; 5(4):577-82. PubMed ID: 2183159
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility and resistance to J3V1 retrovirus-induced murine plasmacytomagenesis in reconstituted severe combined immunodeficient mice.
Hilbert DM; Pumphrey JG; Troppmair J; Rapp UR; Rudikoff S
Oncogene; 1993 Jul; 8(7):1993-2000. PubMed ID: 7685514
[TBL] [Abstract][Full Text] [Related]
9. Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice.
Park SS; Kim JS; Tessarollo L; Owens JD; Peng L; Han SS; Tae Chung S; Torrey TA; Cheung WC; Polakiewicz RD; McNeil N; Ried T; Mushinski JF; Morse HC; Janz S
Cancer Res; 2005 Feb; 65(4):1306-15. PubMed ID: 15735016
[TBL] [Abstract][Full Text] [Related]
10. Selective expression of the murine homologue of the G-protein-coupled receptor BLR1 in B cell differentiation, B cell neoplasia and defined areas of the cerebellum.
Förster R; Wolf I; Kaiser E; Lipp M
Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):381-7. PubMed ID: 7920182
[TBL] [Abstract][Full Text] [Related]
11. Abelson murine leukemia virus transforms preneoplastic Emu-myc transgene-carrying cells of the B-lymphocyte lineage into plasmablastic tumors.
Sugiyama H; Silva S; Wang YS; Weber G; Babonits M; Rosén A; Wiener F; Klein G
Int J Cancer; 1990 Nov; 46(5):845-52. PubMed ID: 2228313
[TBL] [Abstract][Full Text] [Related]
12. Interaction of abl and raf with IL-7 signaling pathway and transformation of pre-B cells from resistant mice.
Hilbert DM; Theisen PW; Rudikoff EK; Bauer SR
Oncogene; 1998 Oct; 17(16):2125-35. PubMed ID: 9798684
[TBL] [Abstract][Full Text] [Related]
13. Tp44 molecules involved in antigen-independent T cell activation are expressed on human plasma cells.
Kozbor D; Moretta A; Messner HA; Moretta L; Croce CM
J Immunol; 1987 Jun; 138(12):4128-32. PubMed ID: 3035021
[TBL] [Abstract][Full Text] [Related]
14. BCL2 accelerates inflammation-induced BALB/c plasmacytomas and promotes novel tumors with coexisting T(12;15) and T(6;15) translocations.
Silva S; Kovalchuk AL; Kim JS; Klein G; Janz S
Cancer Res; 2003 Dec; 63(24):8656-63. PubMed ID: 14695177
[TBL] [Abstract][Full Text] [Related]
15. Influence of genotype and the organ of origin on the subtype of T-cell in Moloney lymphomas induced by transfer of preleukemic cells from athymic and thymus-bearing mice.
Asjö B; Skoog L; Palminger I; Wiener F; Isaak D; Cerny J; Fenyö EM
Cancer Res; 1985 Mar; 45(3):1040-5. PubMed ID: 3871660
[TBL] [Abstract][Full Text] [Related]
16. ABL-MYC retroviral infection elicits bone marrow plasma cell tumors in Bcl-X(L) transgenic mice.
Linden M; Kirchhof N; Kvitrud M; Van Ness B
Leuk Res; 2005 Apr; 29(4):435-44. PubMed ID: 15725478
[TBL] [Abstract][Full Text] [Related]
17. Rapid induction of plasmacytomas in mice by pristane and a murine recombinant retrovirus containing an avian v-myc and a defective raf oncogene.
Potter M; Wax J; Mushinski E; Brust S; Babonits M; Wiener F; Mushinski JF; Mezebish D; Skurla R; Rapp U
Curr Top Microbiol Immunol; 1986; 132():40-3. PubMed ID: 3792042
[No Abstract] [Full Text] [Related]
18. A non-transgenic mouse model for B-cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesis.
Yu D; Thomas-Tikhonenko A
Oncogene; 2002 Mar; 21(12):1922-7. PubMed ID: 11896625
[TBL] [Abstract][Full Text] [Related]
19. Cell populations during tumorigenesis in Eu-myc transgenic mice.
Sidman CL; Shaffer DJ; Jacobsen K; Vargas SR; Osmond DG
Leukemia; 1993 Jun; 7(6):887-95. PubMed ID: 8501983
[TBL] [Abstract][Full Text] [Related]
20. Fidelity and infidelity in commitment to B-lymphocyte lineage development.
Rolink AG; Schaniel C; Busslinger M; Nutt SL; Melchers F
Immunol Rev; 2000 Jun; 175():104-11. PubMed ID: 10933595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]